Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
22 Jun 2021 |
On significant placements in financial instruments |
Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share.
|
Download |
|
29 Apr 2021 |
On business and financial situation |
The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States.
|
Download |
|
12 Apr 2021 |
On business and financial situation |
The Company releases the press release related to its participation in the manufacture of the active substance of Moderna’s COVID-19 vaccine.
|
Download |
|
02 Mar 2021 |
On business and financial situation |
The Company releases an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States
|
Download |
|
02 Mar 2021 |
On business and financial situation |
The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
24 Nov 2020 |
On business and financial situation |
The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day.
|
Download |
|
13 Nov 2020 |
Other relevant information |
The Company informs about the dividends payment
|
Download |
|
05 Nov 2020 |
On business and financial situation |
The company releases the press release related to the 2020 first nine months financial results
|
Download |
|
20 Oct 2020 |
Announcement of general shareholders’ meeting |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
15 Oct 2020 |
Announcement of general shareholders’ meeting |
In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
31 Jan 2020 |
R&D: new licenses, patents and registered trademarks |
The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union
|
Download |
|
08 Jan 2020 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2019
|
Download |
|
20 Dec 2019 |
Composition of the board of directors |
The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees.
|
Download |
|
24 Nov 2019 |
Strategic plans, profit forecasts and presentations |
The Company releases the presentation related to its strategy update because of the 2019 Investor Day.
|
Download |
|
07 Nov 2019 |
Information on P&L |
ROVI releases the press release related to the first nine months 2019 financial results
|
Download |
Pages
